Study aid only. Verify against current guidelines, primary literature, staging manuals, and prescribing information before clinical use.

← All algorithms  ·  Related notes →

Recurrent / Metastatic Salivary Gland Tumors — Systemic Therapy

Recurrent / metastatic salivary gland tumor Biomarker-directed No actionable target Adenoid cystic (ACC) AR+ Androgen deprivation abiraterone / bicalutamide / LHRH ↗ HER2+ HER2-targeted (T-DM1 / T-DXd) trastuzumab ± pertuzumab ↗ NTRK TRK inhibitor laro / entrectinib ↗ RET Selpercatinib LIBRETTO-001 ↗ BRAF Dabrafenib + trametinib ROAR ↗ Chemo Carboplatin / paclitaxel or cisplatin/vinorelbine, CAP TKI Lenvatinib VEGFR-directed ↗ TKI Sorafenib alternative ↗